Polycarbophil calcium

Drug Profile

Polycarbophil calcium

Alternative Names: AHR 3260B; Calcium polycarbophil; Colonel; HSR 237; Polyful; Wl 140

Latest Information Update: 29 Jan 2013

Price : $50

At a glance

  • Originator Abbott Japan
  • Developer Abbott Japan; Astellas Pharma
  • Class Antidiarrhoeals; Irritable bowel syndrome therapies; Laxatives; Polymers
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Irritable bowel syndrome
  • Discontinued Diarrhoea

Most Recent Events

  • 30 May 2005 Clinical trials in Diarrhoea in Japan (PO)
  • 30 May 2005 Data presented at the Digestive Disease Week-2005 conference (DDW-2005) have been added to the Digestive system disorders therapeutic trials section
  • 11 Apr 2005 Yamanouchi has merged with Fujisawa to form Astellas Pharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top